UniSA uses cookies to remember your preferences, analyse traffic, track usage patterns, and personalise content. In some instances, UniSA shares personal information collected by cookies with UniSA's third party service providers and Adelaide University (as UniSA's future successor). See our privacy notification for further details. To adjust your cookie settings, click 'More information'. By clicking 'Accept and continue', you consent to our use of cookies.

UniSA recommends the use of all cookies to provide you with the optimal experience while visiting our website. Choose below to accept the recommended settings or continue to adjust your individual preferences.

Adjust your settings

Essential cookies
Preserves the visitor’s session state across multiple page requests. These cookies are required for basic site functionality and are therefore always enabled.
Analytical cookies
Used to send data through services such as Google Analytics and our advertising platform about a user's device and behaviour. Tracks the user across devices and marketing channels.
Marketing cookies and Advertising based pixels
Track digital activity from ads, optimise ads and remarket to users to customise the website's user experience.

You can opt out of the collection and use of your information for ad targeting. Information for exercising that choice is available at www.aboutads.info/choices and www.youronlinechoices.eu.
Enquiry management cookies
Capture session data for users submitting an enquiry through to our CRM to aid identification of the enquiry source and tailor communications.

Investigating imaging modalities to treat cancers. 

The medical radiations group is involved in the investigation and translation of various imaging modalities for the diagnosis of various cancers, and of novel radiation modalities to treat cancers. The group consists of research expertise across medical imaging, nuclear medicine and radiation therapy – all playing specific roles in diagnosis, staging, treatment and follow-up of cancers.

Radiation therapy is used in treatment of approximately 50% of cancer patients and contributes towards 40% of cancer cures. These days it is often used as part of multimodality treatment in combination with surgery, chemotherapy or even immunotherapy, therefore improving patient treatment outcomes even more.

Explore our research


Our current projects

 

Engage with our team


Find out how you can get involved with our research

 

Our research

The research of our group is multifaceted and includes:

  • preclinical radiobiological studies into head and neck cancers and their treatment response based on Human Papilloma Virus (HPV) status, and
  • investigation of the role and behaviour of clonogenic cancer stem cells during fractionated radiation therapy.

Other research includes development of a proton beam line on a SAHMRI cyclotron for radiobiological experiments using proton beam; as the novel state-of-the-art radiation therapy beam modality currently being developed in Adelaide and in Australia.

In the area of nuclear medicine and theranostics, we are investigating the use of novel alpha emitting radionuclides to target cancer cells in a patient’s body; known as targeted alpha therapy.  

Our group is renowned for world-class radio-biological modelling of radiation interactions with cells and cancers to predict biological outcomes post irradiation.

Other areas of research include development of new dosimetry and microdosimetry detectors to measure radiation dose at a cellular level. In collaboration with the Future Industries Institute, we’re also looking at the implementation and use of metallic nanoparticles (such as gold) as radio-sensitisers in radiation therapy for cancer, with the aim to maximise the damage to cancer cells while protecting healthy tissues.

Latest news from UniSA

Contact us

Medical Radiations

Location Mawson Lakes Campus Mawson Lakes, South Australia 5095 Australia